Preference Study With Elderly Patients Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Topotecan Weekly Versus Topotecan Day 1-5 in Patient With Platin-resistant Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Taxol/ Carboplatin as First Line Therapy in Patients With Epithelial Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Therapy With Topotecan and Carboplatin by Patients With Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Counseling Interventions for BRCA 1/2 Cancer Susceptibility Testing
- Status
- COMPLETED
- Phase
- NA
Evaluating Tools for Health Promotion and Disease Prevention
- Status
- COMPLETED
- Phase
- PHASE1
Taxol Carboplatin and Erythropoetin
- Status
- COMPLETED
- Phase
- PHASE2
GM-CSF, Sargramostim in Women With Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II Study of Modified Triple Doublet Therapy in Women With Newly Diagnosed Mullerian Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
The Development of Human Immunologic Assays Specific to Folate Receptor Antigen
- Status
- UNKNOWN
- Phase
- NA
Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer
- Status
- UNKNOWN
- Phase
- N/A
Mesothelin as a New Tumor Marker for Ovarian Cancer
- Status
- UNKNOWN
- Phase
- N/A
Docetaxel and Carboplatin in Treating Patients With Ovarian Epithelial, Fallopian Tube, or Peritoneal Cavity Cancer
- Status
- COMPLETED
- Phase
- PHASE2
EMD 273066 in Patients With Recurrent EpCAM Positive Ovarian, Prostate, Colorectal or Non-small Cell Lung Cancers When First Given Cyclophosphamide
- Status
- COMPLETED
- Phase
- PHASE1
Carboplatin Taxol Avastin in Ovarian Cancer (OVCA)
- Status
- COMPLETED
- Phase
- PHASE2
Capecitabine and Radiation Therapy in Treating Patients With Locally Advanced Cervical Cancer or Other Pelvic Cancer
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of Carboplatin/Paclitaxel With Pegfilgrastim Supported by Haematopoietic Progenitor Cell Re-Infusion in Whole Blood
- Status
- COMPLETED
- Phase
- PHASE2
Topotecan in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2